Share this post on:

Product Name :
Abrilumab

Search keywords :
Abrilumab

drugId :
null

Target Vo:
Integrin alpha-4/beta-7

Target Vo Short Name :
ITGA4&ITGB7

Moa_Name:
Integrin alpha-4/beta-7 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Amgen Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Crohn Disease

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Recaticimab Purity & Documentation
4-Oct Mouse mAb supplier
Sulfadimidine Antibody (YA906): Sulfadimidine Antibody (YA906) is an unconjugated, rabbit-derived, anti-Sulfadimidine (YA906) monoclonal antibody. Sulfadimidine Antibody (YA906) can be used for: ELISA expriments in background without labeling.

Share this post on:

Author: Interleukin Related